A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Dettagli Bibliografici
Autore principale: Choki, Kinley
Altri autori: Chowdhury, Namara Mariam
Natura: Tesi
Lingua:English
Pubblicazione: Brac University 2024
Soggetti:
Acute lymphoblastic leukemia
Leukemia
R/R B-cell precursor ALL
FDA
Blood cancer
Lymphoblastic leukemia.
Cancer > Immunotherapy.
Monoclonal antibodies > Therapeutic use.
Accesso online:http://hdl.handle.net/10361/24298

Accesso online

http://hdl.handle.net/10361/24298

Documenti analoghi